ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q1 2020 Results - Earnings Call Transcript
Acorda Therapeutics, Inc. (ACOR)
Q1 2020 Earnings Conference Call
May 05, 2020, 16:30 ET
Company Participants
Tierney Saccavino - EVP, Corporate Communications
Ron Cohen - Founder, CEO, President & Director
Conference Call Participants
Michael Yee - Jefferies
Alexander Thompson - Stifel, Nicolaus & Company
Turner Kufe - JPMorgan Chase & Co.
Philip Nadeau - Cowen and Company
Andrea Tan - Goldman Sachs Group
Presentation
Operator
Welcome to the Acorda Therapeutics First Quarter 2020 Update. [Operator Instructions]. Please be advised that this call is being recorded at the company's request. I will now introduce your host